Synnex Technology International Corp (
"We have begun our deployment into China's handset market, and we will start with Motorola back-end logistics operations," Synnex's spokesman Lin Jun-jian (
Synnex, which commenced its operations in China in 1996, is currently the No. 2 distributor of computers and related products in the Chinese market, after US-headquartered Ingram Micro Inc.
Though Synnex has distributorships in China and other countries, it only supplies handset products in Taiwan and India, and the partnership with Motorola will further its efforts to expand handset business overseas, Lin said.
The deal, which is yet to be sealed, will offer back-end services such as cash flow, logistics and after-sale maintenance services to Motorola.
The long-term plan is to become the country-wide distributor for Motorola phones in China, he said.
Currently, Synnex has 23 ware-houses in China, and a logistics hub in Shanghai.
There will be two more logistics hubs established in Beijing and Chengdu next year, and two others in Nanjing and Guangzhou in 2008, Lin said.
"This will complete our logistics network in China, and secure our leadership as a distributor offering complete logistics services there," he said.
The next two years in China will be an expansion period for Synnex, which will spend another NT$1.5 billion (US$45.7 million) to grow its operations.
Synnex posted overseas sales of NT$7.4 billion last month, up 18 percent, year on year.
Last month figures accounted for 65 percent of Synnex's total sales, and the contribution of overseas revenue will rise to 80 percent in the next two years, the company said.
Annual handset sales in Taiwan are around 7 million units, which is equivalent to the monthly sales in China, the world's handset market.
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March